Evidence map›Paper›PMID 42073623›Full record

ArticleCancers2026

Impact of Neoadjuvant Chemotherapy Administration Time of Day on Pathological Response in Patients with Early Triple-Negative Breast Cancer.

Clémentine Bouchez, Simona Catozzi, Laetitia Someil, Caroline Cuvier, Léonor Drouin, Luis Teixeira, Catherine Miquel, Cédric De Bazelaire, Francis Levi, Jimmy Mullaert and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Clémentine BouchezAssistance Publique Hôpitaux de Paris (APHP), Saint Louis Hospital, Breast Diseases Unit, 75010 Paris, France.
Simona CatozziCancer Systems Pharmacology, Inserm U1331, Institut Curie, PSL Research University, CBIO-Center for Computational Biology, Mines Paris, 75248 Saint-Cloud, France.
Laetitia SomeilAssistance Publique Hôpitaux de Paris (APHP), Saint Louis Hospital, Breast Diseases Unit, 75010 Paris, France.
Caroline CuvierAssistance Publique Hôpitaux de Paris (APHP), Saint Louis Hospital, Breast Diseases Unit, 75010 Paris, France.
Léonor DrouinAssistance Publique Hôpitaux de Paris (APHP), Saint Louis Hospital, Breast Diseases Unit, 75010 Paris, France.ORCID 0000-0001-9091-2182
Luis TeixeiraAssistance Publique Hôpitaux de Paris (APHP), Saint Louis Hospital, Breast Diseases Unit, 75010 Paris, France.
Catherine MiquelSaint Louis Hospital, Department of Pathology, APHP, 75010 Paris, France.
Cédric De BazelaireSaint Louis Hospital, Department of Radiology, APHP, 75010 Paris, France.
Francis LeviInserm Unit 1193 HEPAREG, Faculty of Medicine, Paris-Saclay University, 94800 Villejuif, France.ORCID 0000-0003-1364-7463
Jimmy MullaertUniversity of Versailles Saint-Quentin, Faculty of Medicine, 78646 Versailles, France.
Annabelle BallestaCancer Systems Pharmacology, Inserm U1331, Institut Curie, PSL Research University, CBIO-Center for Computational Biology, Mines Paris, 75248 Saint-Cloud, France.ORCID 0000-0001-7204-1205
Sylvie GiacchettiAssistance Publique Hôpitaux de Paris (APHP), Saint Louis Hospital, Breast Diseases Unit, 75010 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

administration time of daychronotherapycircadian drug timingdose-dense, dose-intense neoadjuvant chemotherapyprecision medicinetriple-negative breast cancer

Identifiers

PMID42073623
PMCPMC13114987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.